6472 — Bora Pharmaceuticals Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapFalling Star

Annual income statement for Bora Pharmaceuticals Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	R2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	4,900	10,494	14,200	17,427	19,014
Cost of Revenue
Gross Profit	1,672	2,913	6,991	7,791	7,853
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	3,854	8,572	8,951	12,056	15,721
Operating Profit	1,046	1,922	5,249	5,371	3,294
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	1,024	1,840	4,064	5,223	5,278
Provision for Income Taxes
Net Income After Taxes	750	1,402	3,072	4,218	4,448
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	750	1,392	3,030	3,853	2,981
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	750	1,395	3,044	3,927	3,154
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	6.43	11.8	24.5	21.2	33.6
Dividends per Share